
Rami Komrokji, MD, discusses the importance of establishing a clinical consensus to standardize the use of molecular testing in myelodysplastic syndromes.
This 2-day event is designed as a consensus conference to address the need for conclusive guidelines on disease management; it includes faculty from several cancer centers to represent the scientific community. Based on the findings, we will provide guidance to practicing clinicians.

Rami Komrokji, MD, discusses the importance of establishing a clinical consensus to standardize the use of molecular testing in myelodysplastic syndromes.

Amrita Krishnan, MD, discusses the challenges in developing a clinical consensus on risk stratification in smoldering multiple myeloma and its role in guiding treatment decisions.